MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-14-2023
Adamis Pharmaceuticals Corporation Total Inventories 2011-2026 | ADMP
Annual Total Inventories Adamis Pharmaceuticals Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.24 M | 419 K | 3.12 M | 2.06 M | 3.28 M | 1.82 M | 942 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.28 M | 419 K | 1.84 M |
Quarterly Total Inventories Adamis Pharmaceuticals Corporation
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 663 K | 664 K | 1.24 M | 1.09 M | 440 K | 32 K | 419 K | - | 2.17 M | 2.56 M | 1.23 M | 1.23 M | 3.12 M | 3.12 M | 2.06 M | 2.06 M | 2.06 M | 2.06 M | 3.28 M | 3.28 M | 3.28 M | 3.28 M | 1.82 M | 1.82 M | 1.82 M | 1.82 M | 942 K | 942 K | 942 K | 942 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.28 M | 32 K | 1.74 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | USA |
 |
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | - | - | $ 2.06 B |  France |
 |
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
329 M | $ 8.28 | 3.31 % | $ 424 M | USA |
 |
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
482 K | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 3.33 | 6.39 % | $ 46.8 M | USA |
 |
Rockwell Medical
RMTI
|
5.87 M | $ 1.07 | 3.88 % | $ 25 M | USA |
 |
Bausch Health Companies
BHC
|
1.54 B | $ 5.17 | 3.4 % | $ 1.89 B |  Canada |
 |
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | USA |
 |
Pacira BioSciences
PCRX
|
125 M | $ 23.36 | 0.67 % | $ 1.08 B | USA |
 |
ProPhase Labs
PRPH
|
3.98 M | - | - | $ 5.07 M | USA |
 |
Evolus
EOLS
|
27 M | $ 4.45 | 0.34 % | $ 287 M | USA |
 |
Perrigo Company plc
PRGO
|
1.15 B | $ 9.63 | -0.1 % | $ 1.33 B | USA |
 |
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | USA |
 |
Tilray
TLRY
|
201 M | $ 6.99 | 4.95 % | $ 4.32 B | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 2.35 | 0.43 % | $ 2.92 M | USA |
 |
SCYNEXIS
SCYX
|
899 K | $ 0.91 | 0.57 % | $ 45.4 M | USA |
 |
Jupiter Wellness
JUPW
|
234 K | - | - | $ 33.6 M | USA |
 |
Veru
VERU
|
4.14 M | $ 2.33 | 1.75 % | $ 314 M | USA |
 |
Viatris
VTRS
|
3.52 B | $ 13.65 | 2.13 % | $ 16.4 B | USA |
 |
China Pharma Holdings
CPHI
|
2.27 M | $ 0.62 | 8.98 % | $ 10.8 M |  China |
 |
cbdMD
YCBD
|
2.52 M | $ 0.79 | 0.86 % | $ 3.41 M | USA |
 |
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | USA |
 |
Organogenesis Holdings
ORGO
|
26.2 M | $ 2.47 | 2.49 % | $ 325 M | USA |
 |
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.0 | 3.86 % | $ 108 M | Canada |
 |
Assertio Holdings
ASRT
|
24.1 M | $ 17.53 | 6.18 % | $ 112 M | USA |
 |
TherapeuticsMD
TXMD
|
7.99 M | $ 2.4 | 4.8 % | $ 25.1 M | USA |
 |
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | USA |
 |
Harrow Health
HROW
|
13.5 M | $ 35.82 | 1.76 % | $ 1.32 B | USA |